AVX-470, AN ORALLY DELIVERED ANTI-TNF ANTIBODY FOR TREATMENT OF ACUTE ULCERATIVE COLITIS: RESULTS OF A FIRST-IN-HUMAN TRIAL

M Harris  1     Deborah Hartman  1     Sharon C Spence  1     Sally Kennedy  1     Theodore Ptak  2     Ronald Pruitt  3     Severine Vermeire  4     Barbara Fox    
1 Avaxia Biologics, Lexington, United States
2 Toronto Digestive Disease Associates, Toronto, Canada
3 Nashville Medical Research Institute, Nashville, United States
4 Medicine, University Hospital Gasthuisbe

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing